Novartis AG
SIX:NOVN

Watchlist Manager
Novartis AG Logo
Novartis AG
SIX:NOVN
Watchlist
Price: 107.08 CHF 0.19% Market Closed
Market Cap: 205.5B CHF

Relative Value

The Relative Value of one NOVN stock under the Base Case scenario is hidden CHF. Compared to the current market price of 107.08 CHF, Novartis AG is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NOVN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
29
Median 3Y
4.2
Median 5Y
4.1
Industry
2.6
Forward
4.5
vs History
39
vs Industry
26
Median 3Y
17.3
Median 5Y
17.2
Industry
21.7
Forward
14.6
vs History
41
vs Industry
32
Median 3Y
12.1
Median 5Y
12
Industry
16.6
vs History
60
vs Industry
27
Median 3Y
18.4
Median 5Y
19.5
Industry
22.5
vs History
6
vs Industry
13
Median 3Y
5
Median 5Y
3.7
Industry
2.3
vs History
3
vs Industry
26
Median 3Y
4.5
Median 5Y
4.2
Industry
2.9
Forward
4.8
vs History
12
vs Industry
34
Median 3Y
6
Median 5Y
5.9
Industry
5.5
vs History
26
vs Industry
30
Median 3Y
10.8
Median 5Y
10.4
Industry
13.1
Forward
11.4
vs History
71
vs Industry
29
Median 3Y
16.5
Median 5Y
15.7
Industry
16.6
Forward
12.7
vs History
42
vs Industry
30
Median 3Y
12.7
Median 5Y
12.6
Industry
15.8
vs History
39
vs Industry
25
Median 3Y
15.8
Median 5Y
15.7
Industry
19.1
vs History
1
vs Industry
26
Median 3Y
2.6
Median 5Y
2.1
Industry
1.9

Multiples Across Competitors

NOVN Competitors Multiples
Novartis AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Novartis AG
SIX:NOVN
205.5B CHF 4.6 17.7 11.3 14.6
US
Eli Lilly and Co
NYSE:LLY
955.6B USD 16.1 51.9 34.9 37.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
485.9B USD 5.3 19.3 15.8 20.5
CH
Roche Holding AG
SIX:ROG
247.5B CHF 4 26.2 11.8 13.4
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.8 29.9 108.4 158.6
US
Merck & Co Inc
NYSE:MRK
248B USD 3.9 13 9.3 11
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.2 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
148B USD 2.4 15.1 7.6 10.4
FR
Sanofi SA
PAR:SAN
103.5B EUR 1.5 7.5 6.8 6.8
P/E Multiple
Earnings Growth PEG
CH
Novartis AG
SIX:NOVN
Average P/E: 21.6
17.7
17%
1
US
Eli Lilly and Co
NYSE:LLY
51.9
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.2
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.9
38%
0.8
US
Merck & Co Inc
NYSE:MRK
13
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
15.1
29%
0.5
FR
Sanofi SA
PAR:SAN
7.5
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CH
Novartis AG
SIX:NOVN
Average EV/EBITDA: 398.4
11.3
6%
1.9
US
Eli Lilly and Co
NYSE:LLY
34.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.8
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
4%
3
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
FR
Sanofi SA
PAR:SAN
6.8
8%
0.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CH
Novartis AG
SIX:NOVN
Average EV/EBIT: 1 708.3
14.6
12%
1.2
US
Eli Lilly and Co
NYSE:LLY
37.4
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
US
Merck & Co Inc
NYSE:MRK
11
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3
FR
Sanofi SA
PAR:SAN
6.8
15%
0.5